NewGenIvf Group Limited Class A Ordinary Shares (NASDAQ:NIVF) — Stock Price
NewGenIvf Group Limited Class A Ordinary Shares (NASDAQ:NIVF) is currently trading at $0.61 USD, down 3.24% today. Over the past 52 weeks, shares have ranged between $0.30 and $2.49. This page tracks NewGenIvf Group Limited Class A Ordinary Shares's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see NewGenIvf Group Limited Class A Ordinary market cap and net worth.
NewGenIvf Group Limited Class A Ordinary Shares (NIVF) Stock Price Chart — Daily History & Trading Volume
The chart below tracks NewGenIvf Group Limited Class A Ordinary Shares's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
NewGenIvf Group Limited Class A Ordinary Shares Income Statement — Revenue, Profit & Earnings by Year
NewGenIvf Group Limited Class A Ordinary Shares's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Revenue | $5.43 Million | $5.14 Million | $5.94 Million | $4.12 Million |
| Cost of Revenue | $3.61 Million | $3.45 Million | $4.41 Million | $3.09 Million |
| Gross Profit | $1.83 Million | $1.68 Million | $1.54 Million | $1.02 Million |
| Research & Development | — | — | — | — |
| SG&A | $2.78 Million | $1.62 Million | $1.10 Million | $801.33K |
| Total Operating Expenses | $2.80 Million | $2.52 Million | $1.14 Million | $826.02K |
| Operating Income | $-1.16 Million | $-2.52 Million | $-504.91K | $198.76K |
| EBITDA | $24.26K | $-2.52 Million | $725.69K | $587.01K |
| EBIT | $-182.00K | $-2.75 Million | $421.75K | $244.47K |
| Interest Expense | $778.66K | $46.18K | $77.76K | $88.29K |
| Income Before Tax | $-961.00K | $-690.85K | $500.65K | $156.18K |
| Income Tax Expense | $-487.00K | $-229.71K | $208.14K | $294.72K |
| Net Income | $-525.00K | $-690.85K | $458.67K | $-533.00 |
NewGenIvf Group Limited Class A Ordinary Shares Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes NewGenIvf Group Limited Class A Ordinary Shares's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Assets | $3.58 Million | $21.32 Million | $70.79 Million | $1.41 Million |
| Total Current Assets | $3.17 Million | $50.78K | $91.73K | $820.39K |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | $11.88K | — | — | — |
| Net Receivables | $2.36 Million | $1.02 Million | $2.32 Million | $750.35K |
| Inventory | $80.81K | $126.26K | $46.91K | $41.27K |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | — | — | — | — |
| Total Liabilities | $5.06 Million | $5.72 Million | $2.46 Million | $2.33 Million |
| Total Current Liabilities | $2.72 Million | $2.24 Million | $50.00K | $2.07 Million |
| Long-term Debt | $2.33 Million | — | — | — |
| Net Debt | $2.57 Million | $1.58 Million | $397.32K | $897.20K |
| Total Stockholder Equity | $-1.05 Million | $15.60 Million | $68.32 Million | $-775.94K |
| Retained Earnings | $-985.99K | $-5.67 Million | $-591.54K | $-1.05 Million |
NewGenIvf Group Limited Class A Ordinary Shares Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how NewGenIvf Group Limited Class A Ordinary Shares generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Operating Cash Flow | $-8.26 Million | $-857.36K | $-527.12K | $1.43 Million |
| Capital Expenditures | $53.04K | $69.85K | $94.45K | $16.57K |
| Free Cash Flow | $-8.32 Million | $-927.20K | $-621.58K | $1.42 Million |
| Investing Cash Flow | $-53.05K | — | $-69.69 Million | $-16.57K |
| Financing Cash Flow | $8.68 Million | $-50.41 Million | $70.27 Million | $-1.54 Million |
| Dividends Paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Stock-Based Compensation | — | — | — | — |
| Depreciation | $206.26K | $229.71K | $303.94K | $342.54K |
| Change in Cash | $403.64K | $-12.49K | $54.72K | $-77.43K |
NewGenIvf Group Limited Class A Ordinary Shares Earnings History — EPS Actual vs. Analyst Estimates
Track NewGenIvf Group Limited Class A Ordinary Shares's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Oct 10, 2025 | 0.73 | 0.00 | — |
| May 15, 2025 | 0.00 | 0.00 | — |
| Dec 31, 2024 | -23.77 | — | — |
| Dec 05, 2024 | -0.04 | — | — |
| Dec 31, 2023 | -1282.03 | — | — |
| Sep 30, 2023 | 117.14 | — | — |
| Jun 30, 2023 | 78.85 | — | — |
| May 11, 2023 | 0.01 | — | — |